Testicular cancer (TC) predominantly affects young men and early detection enhances survival. However, uncertainty surrounds the impact of population-wide screening. Testicular self-examination (TSE) is a simple detection method but there is a gap in current practices that needs to be assessed. Our goal was to assess the perceptions and knowledge of male subjects in the general population (MP) and general practitioners (GPs) regarding TSE for TC.
Two distinct surveys evaluating knowledge and perceptions of TSE for TC were administered to GPs and MP, aged 15‒45-years. Factors that could favour the realisation of TSE or improve the knowledge of TC were evaluated by multivariable logistic regression.
Overall, 1048 GPs (mean (SD) age: 35.1 ± 10.3 years) and 1032 MP (mean (SD) age: 27 ± 8.2 years) answered the survey. Among the GPs, only 93 (8.9%) performed scrotal examination for TC screening. Although the majority (n = 993, 94.8%) were aware of the age of onset of TC, most (n = 768, 73.3%) did not know the overall survival rate from TC. GPs familiar with the guidelines were more likely to explain TSE to their patients (OR = 2.5 [95% CI 1.5‒4.1]; p < 0.01). Among the MP, 800 (77.5%) admitted that they did not know how to perform TSE and 486 (47.1%) did not know the main symptoms associated with TC. MP who had already undergone TC screening were more likely to be familiar with the main symptoms (OR = 2.1 [95% CI 1.6‒2.7]; p < 0.001) and MP who knew someone with TC or who had already undergone TC screening were more likely to be aware of the correct prevalence of TC (OR = 1.9 [95% CI 1.3‒2.7], p < 0.01; and OR = 1.6 [95% CI 1.2‒2.1], p < 0.01; respectively).
The knowledge of both GPs and MP regarding TC could be improved. TSE screening and knowing someone close with TC improved the awareness of our subjects.
World journal of urology. 2024 Jan 27*** epublish ***
Quentin Boisselier, Ugo Pinar, Xavier Durand, Thomas Tabourin, Ambroise Salin, Michael Baboudjian, Thibaut Murez, Morgan Roupret, Benjamin Pradère
Tours University, Tours, France., GRC n°5, Predictive Onco-Urology, APHP, Sorbonne University, Hôpital Pitié-Salpêtrière, Urology, 75013, Paris, France., Urology Department, Hôpital Saint-Joseph, Paris, France., Department of Urology, La Croix du Sud Hospital, 31130, Quint Fonsegrives, France., Department of Urology, North Hospital, Aix-Marseille University, APHM, Marseille, France., Urology and Renal Transplantation Department, CHU Lapeyronie, Montpellier, France., Department of Urology, La Croix du Sud Hospital, 31130, Quint Fonsegrives, France. .